IL-1β, IL-6, and TNFα are considered markers of neuroinflammation due to their presence in higher to lower graded concentrations in AD, MCI, and control patients, respectively (Leonardo and Fregni, 2023). This evidence concerns the gene IL1B and Alzheimer disease.